Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

ClinicalTrials.gov ID: NCT04305275

Public ClinicalTrials.gov record NCT04305275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 8:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Placebo-controlled, Randomized Study Evaluating the Efficacy, Safety, and Tolerability of Sage-324 in the Treatment of Individuals With Essential Tremor

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 2, double-blind, placebo-controlled study to evaluate the safety and efficacy of SAGE-324 compared to placebo on upper limb (UL) tremor reduction in individuals with essential tremor (ET).

Study identification

NCT ID
NCT04305275
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sage Therapeutics
Industry
Enrollment
69 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 19, 2020 (Actual)
Primary completion
Feb 1, 2021 (Actual)
Completion
Feb 15, 2021 (Actual)
Last update posted
Apr 17, 2024

2020 – 2021

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Sage Investigational Site Phoenix Arizona 85258 —
Sage Investigational Site Rogers Arkansas 72758 —
Sage Investigational Site Fresno California 93710 —
Sage Investigational Site Long Beach California 90806 —
Sage Investigational Site Englewood Colorado 80113 —
Sage Investigational Site Boca Raton Florida 33486 —
Sage Investigational Site Gainesville Florida 32608 —
Sage Investigational Site Hollywood Florida 33024 —
Sage Investigational Site Miami Florida 33136 —
Sage Investigational Site Miami Florida 33176 —
Sage Investigational Site Port Charlotte Florida 33980 —
Sage Investigational Site St. Petersburg Florida 33713 —
Sage Investigational Site Tampa Florida 33609 —
Sage Investigational Site Decatur Georgia 30030 —
Sage Investigational Site Savannah Georgia 31406 —
Sage Investigational Site Springfield Illinois 62702 —
Sage Investigational Site Kansas City Kansas 66160 —
Sage Investigational Site Farmington Hills Michigan 48334 —
Sage Investigational Site New York New York 10032 —
Sage Investigational Site Asheville North Carolina 28806 —
Sage Investigational Site Cincinnati Ohio 45212 —
Sage Investigational Site Dayton Ohio 45417 —
Sage Investigational Site Tulsa Oklahoma 74136 —
Sage Investigational Site Houston Texas 77030 —
Sage Investigational Site Richmond Virginia 23229 —
Sage Investigational Site Spokane Washington 99202 —
Sage Investigational Site Huntington West Virginia 25701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04305275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2024 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04305275 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →